Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Good Simulation Practice (GSP) Task Force

Good Simulation Practice (GSP) Task Force

BACK

Good Simulation Practice (GSP) Task Force

Mission: Drafting a Good Simulation Practice document widely recognized and accepted similar to the Good Clinical Practice

In today's rapidly evolving medical landscape, computational modeling and simulation, known as in silico techniques, are increasingly prominent. These techniques bring along efficiency, precision, and cost-effectiveness, but they demand universally recognized standards for consistency and credibility.

With a steadfast commitment to elevating the standards of
in silico methods, the GSP Task Force is set to pioneer and shape the computational modelling frontier in Europe and beyond.

The
GSP paper “Toward Good Simulation Practice - Best Practices for the Use of Computational Modelling and Simulation in the Regulatory Process of Biomedical Products”has just been published on 23 February 2024.

This publication involved the collaboration of 144 experts, part of Avicenna Alliance, VPH Institute, and the EU-funded project InSilicoWorld, and coming from academia, industry, and regulatory agencies (including 13 M&S experts from the FDA’ s ModSimWG).

Goals

  • Generate support to tackle the lack of regulatory framework for CM&S by outreach to key stakeholders that should have an interest in the development of GSP Guidelines: now contributors and 1 publication of CoU
  • Engage with regulators (EMA, FDA) to endorse the development of GSP Guidance document
  • Develop a GSP guidance document to provide to regulators


Luca Emili

Luca Emili

Co-Chair of the Good Simulation Practice (GSP) Task Force

CEO, InSilicoTrials Technologies

READ BIO

NEWS

News Virtual launch of

Virtual launch of "Toward Good Simulation Practice" book

On May 8, 2024, the virtual launch of "Toward Good Simulation Practice: Best Practices for the Use of Computational Modeling and Simulation (CM&S) in the Regulatory Process of Biomedical Products" took place, marking a significant milestone in regulatory science and industry.

News Appointment of Avicenna Formal Administrators

Appointment of Avicenna Formal Administrators

At its recent General Assembly, the members of the Avicenna Alliance have confirmed that three members of the Avicenna Board will act as legal representatives of the Avicenna Alliance. As a Belgian non-profit organisation, the Avicenna Alliance allocate the following positions:

News Avicenna at FDA / MDIC Event in Washington, April 16 - 17

Avicenna at FDA / MDIC Event in Washington, April 16 - 17

Many representatives of the Avicenna Alliance networked with good friends and in silico thought leaders from around the world at the FDA / MDIC symposium on Computation Modeling & Simulation in Washington.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry